Abstract
Chronic kidney disease (CKD) is now understood to affect over 5% of all adult patients and it conveys a risk of reduced survival in those affected. At least 80% of those patients with stages 3-5 CKD (i.e. GFR
| Original language | English |
|---|---|
| Pages (from-to) | 4-10 |
| Number of pages | 6 |
| Journal | Journal of Renal Care |
| Volume | 33 |
| Issue number | 1 |
| Publication status | Published - Jan 2007 |
Keywords
- Angiotensin converting enzyme inhibitor
- Angiotensin receptor blockers
- Cardiovascular risk
- Chronic kidney disease
- Diabetic nephropathy
- Hypertension
- Renovascular disease
